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Abstract
Background & Aims: While non-alcoholic steatohepatitis (NASH) is characterized by hepatic steatosis combined
with inflammation, the mechanisms triggering hepatic inflammation are unknown. In Ldlr-/- mice, we have previously
shown that lysosomal cholesterol accumulation in Kupffer cells (KCs) correlates with hepatic inflammation and
cholesterol crystallization. Previously, cholesterol crystals have been shown to induce the activation of
inflammasomes. Inflammasomes are protein complexes that induce the processing and release of pro-inflammatory
cytokines IL-1b and IL-18 via caspase-1 activation. Whereas caspase-1 activation is independent of caspase-11 in
the canonical pathway of inflammasome activation, caspase-11 was found to trigger caspase-1-dependent IL-1b and
IL-18 in response to non-canonical inflammasome activators. So far, it has not been investigated whether
inflammasome activation stimulates the formation of cholesterol crystals. We hypothesized that inflammasome
activation in KCs stimulates cholesterol crystallization, thereby leading to hepatic inflammation.
Methods: Ldlr-/- mice were transplanted (tp) with wild-type (Wt) or caspase-1/11-/- (dKO) bone marrow and fed either
regular chow or a high-fat, high-cholesterol (HFC) diet for 12 weeks. In vitro, bone marrow derived macrophages
(BMDM) from wt or caspase-1/11-/- mice were incubated with oxLDL for 24h and autophagy was assessed.
Results: In line with our hypothesis, caspase-1/11-/--tp mice had less severe hepatic inflammation than Wt-tp
animals, as evident from liver histology and gene expression analysis in isolated KCs. Mechanistically, KCs from
caspase-1/11-/--tp mice showed less cholesterol crystals, enhanced cholesterol efflux and increased autophagy. In wt
BMDM, oxLDL incubation led to disturbed autophagy activity whereas BMDM from caspase-1/11-/- mice had normal
autophagy activity.
Conclusion: Altogether, these data suggest a vicious cycle whereby disturbed autophagy and decreased cholesterol
efflux leads to newly formed cholesterol crystals and thereby maintain hepatic inflammation during NASH by further
activating the inflammasome.
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Introduction
Non-alcoholic fatty liver disease (NAFLD) constitutes a
spectrum of liver diseases characterized by hepatic lipid
accumulation (steatosis), which when combined with hepatic
inflammation is known as non-alcoholic steatohepatitis (NASH).
While steatosis itself is generally considered a rather harmless
and reversible condition that is present in about two thirds of
patients with metabolic syndrome, the presence of
inflammation in a fatty liver drives disease progression and
allows the disease to develop to more advanced stages – such
as fibrosis, cirrhosis or hepatocellular carcinoma – ultimately
requiring liver transplantation [1]. Currently, the mechanisms
underlying hepatic inflammation are unknown. Consequently,
therapeutic options are poor and non-invasive markers to
detect NASH do not exist. It is therefore important to
investigate the underlying mechanisms that trigger the hepatic
inflammatory response in the progression to NASH.
Previously, in mice lacking the low-density lipoprotein
receptor (Ldlr-/-), we have shown that hepatic inflammation is
initiated by Kupffer cells (KCs) [2], which scavenge oxidized
lipoproteins rich in cholesterol, leading to an accumulation of
cholesterol inside the lysosomes of KCs and the formation of
cholesterol crystals [3,4]. Cholesterol crystals have been
shown to induce the activation of inflammasomes [5].
Inflammasomes are large multi-protein complexes that, via
caspase-1 activation, trigger the maturation of the pro-
inflammatory cytokines interleukin-1b (IL-1b) and interleukin-18
(IL-18), which then engage in innate immune defense and
sustain inflammation [6–8]. Whereas caspase-1 activation is
independent of caspase-11 in the canonical pathway of
inflammasome activation, pro-inflammatory caspase-11 was
found to be essential for LPS-induced IL-1b secretition in vivo
[9] and trigger caspase-1 dependent IL-1b and IL-18 in
response to non-canonical inflammasome activators [10]. So
far, the contribution of hematopoietic inflammasome activation
to the formation of cholesterol crystals has not been
investigated. We hypothesized that inflammasome activation in
KCs stimulates the formation of cholesterol crystals, thereby
leading to inflammation in the liver.
To test this hypothesis, we transferred bone marrow cells
from donor mice lacking caspase-1 and caspase-11 (dKO) into
lethally irradiated hyperlipidemic Ldlr-/- recipient mice. In line
with our hypothesis, when these mice were fed an HFC diet,
deletion of caspase-1/11 in KCs resulted in less hepatic
inflammation compared to controls, which was independent of
the development of hepatic steatosis. Interestingly, lysosomal
dysfunction and cholesterol crystallization inside KCs was
lower in caspase-1/11-/--tp mice on HFC diet than in Wt-tp mice.
Mechanistically, we show that cholesterol efflux and autophagy
are involved in inflammasome induced cholesterol
crystallization. Additionally, we strengthen our in vivo findings
in vitro, as BMDM from Wt mice had affected autophagic
activity whereas caspase-1/11-/- BMDM had normal autophagic
activity upon oxLDL incubation. These data suggest a vicious
cycle whereby disturbed autophagy and decreased cholesterol
efflux leads to newly formed cholesterol crystals that further
enhance the activation of the inflammasome and thereby
maintain hepatic inflammation. Taken together, our data
propose that inflammasome activation contributes to the
sustained inflammatory response in the liver via the formation
of cholesterol crystals. Therefore, inhibiting the inflammatory
cascade induced by inflammasome activation in KCs or
abrogating the cholesterol crystallization process by restoring
autophagy or cholesterol efflux may be beneficial for the
treatment of NASH.
Methods
Mice, diet and bone marrow transplantation
Mice were housed under standard conditions and given
unlimited access to food and water. Experiments were
performed according to Dutch regulations and approved by the
Committee for Animal Welfare of Maastricht University. Female
10-12 week old Ldlr-/- mice were lethally irradiated and
transplanted with Wt or caspase-1/11-/- bone marrow as
previously described [2]. Caspase-1/11-/- mice were a kind gift
from Prof. Netea, Department of Medicine, Radboud University
Nijmegen Medical Centre and Nijmegen Institute for Infection,
Inflammation and Immunity (N4i), Nijmegen, The Netherlands.
All mice were backcrossed ten generations to C57Bl/6J mice,
and age-matched wild-type C57Bl/6J mice were used as
controls throughout the different experiments. Besides
caspase-1, these mice are known to have defective
caspase-11, essentially making them doubly deficient in
caspase-1 and caspase-11 [10]. Efficiency of the bone marrow
transplantation was approximately 98% (data not shown). After
9 weeks of recovery, mice were given either chow or HFC diet
for 3 months (Wt-tp chow: n=11; HFC: n=12; caspase-1/11-/--tp
chow: n=11; HFC: n=14). The HFC diet contained 21% milk
butter, 0.2% cholesterol, 46% carbohydrates and 17% casein.
Collection of blood and tissue specimens, biochemical
determination of plasma and liver lipids, liver histology, electron
microscopy, Kupffer cell isolation, cathepsin D activity assay, in
vitro macrophage culture, western blotting, RNA isolation,
cDNA synthesis and qPCR were performed as described
previously [2–4,11–13].
Autophagy analysis
In electron microscopy pictures autophagy analysis was
performed by counting lipid droplets with a double membrane
(autophagosomes) in 40 Kupffer cells from each transplanted
group and calculating the average autophagosome number per
Kupffer cell. In order to score cholesterol crystallization in
Kupffer cells, electron microscopy pictures of 30 Kupffer cells
from each experimental group were investigated for the amount
of cholesterol crystals present. Each Kupffer cell was given a
score in the range 0 to 5; 0 indicates that no cholesterol
crystals were present while 5 indicates the highest amount of
cholesterol crystals present.
Statistical analysis
The data were analyzed using Graphpad Prism 4.0.3
(GraphPad Software, Inc., La Jolla, CA, USA). The unpaired t-
test was performed for comparing Wt-tp and caspase-1/11-/--tp
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mice for each diet group and for comparing Wt and
caspase-1/11-/- BMDM. The data were expressed as the mean
and standard error of the mean (SEM) and were considered
significantly different at *p<0.05; ** p<0.01; *** p<0.001.
Results
Hematopoietic deletion of caspase-1/11 has no effect
on plasma and liver lipid levels
As expected, the levels of triglycerides (TG), total cholesterol
(TC) and free fatty acids (FFA) in both plasma and liver were
higher after 3 months of HFC feeding than after 3 months of
chow diet. However, no differences in plasma lipid
concentrations were found between Wt-tp and caspase-1/11-/--
tp mice on HFC diet (Figure 1A). In line with these data, HFC
feeding resulted in equal levels of steatosis in the two
transplanted groups, as indicated by biochemical
measurements of lipids in the liver (Figure 1B) and oil red O
staining (Figure 1C). No difference in weight between the
different groups was observed. Taken together, these data
demonstrate that hematopoietic inflammasome activation has
no effect on lipid concentrations in plasma and liver.
Less hepatic inflammation in caspase-1/11-/--tp mice on
HFC diet
To determine the effect of caspase-1 and caspase-11
deletion in KCs on hepatic inflammation during the
development of NASH, we performed immunohistochemical
Figure 1.  Plasma and liver lipid levels.  (A) Plasma total triglycerides (TG), total cholesterol (TC) and free fatty acids (FFA) after 3
months on a chow or HFC diet in Wt-tp and caspase-1/11-/--tp mice. (B) Liver TG, TC and FFA after 3 months on chow or HFC diet.
(C) Representative images (100x magnification) of the Oil Red O staining of liver sections from Wt-tp and caspase-1/11-/--tp mice on
HFC for 3 months. Data are represented as mean +/- SEM.
doi: 10.1371/journal.pone.0078792.g001
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analysis using inflammatory markers. Scoring of stained
sections for infiltrated macrophages (Mac1) (p=0.007),
neutrophils (NIMP) (p=0.0043) and T cells (KT3) (p=0.0028)
revealed there to be less hepatic inflammation in
caspase-1/11-/--tp mice than in Wt-tp mice on HFC diet (Figure
2A, B, C). Clustering of inflammatory cells, when present, was
also more pronounced in the livers of Wt-tp mice than in those
of caspase-1/11-/--tp animals (Figure 2D).
To determine the direct contribution of inflammasome
activation in KCs to the inflammatory response in the liver, we
analyzed inflammatory gene expression in isolated KCs from
both transplanted groups. Isolated KCs from caspase-1/11-/--tp
mice had lower expression of Tnf-a (p=0.0421), IL-1β
(p=0.007), IL18 (p=0.005) and Ccl5 (p=0.003) than those from
Wt-tp mice on HFC diet (Figure 2E). These gene expression
data support our histological findings and confirm that the
milder hepatic inflammation observed in caspase-1/11-/--tp mice
is a result of caspase-1 and caspase-11 deletion, specifically in
KCs.
Although fibrosis development was only moderate, scoring of
the Sirius Red-stained liver sections revealed collagen content
to be lower in the livers of caspase-1/11-/--tp mice than in those
of Wt-tp mice (p=0.0481) (Figure S1A-C). However, hepatic
gene expression of the fibrosis-related genes transforming
growth factor β (Tgf-β) and collagen 1A1 (Col1a1) was not
significantly different between the transplanted groups (Figure
S1D). No differences in plasma ALT levels were observed
between Wt-tp and caspase-1/11-/--tp mice (Figure S1E).
Figure 2.  Parameters of hepatic inflammation.  (A-C) Liver sections were stained for infiltrated macrophages and neutrophils
(Mac-1), neutrophils (NIMP) and T cells (CD3+). (D) Representative pictures of Mac-1 staining (200x magnification) after 3 months of
HFC feeding in Wt-tp and caspase-1/11-/--tp mice. (E) Gene expression of pro-inflammatory cytokines tumor necrosis factor alpha
(TNFα), interleukin 1 beta (IL1β), interleukin 18 (IL18) and chemokine (C-C motif) ligand 5 (CCL5) in isolated KCs. Data are
represented as mean +/- SEM and were set relative to the Wt-tp group on chow diet. * and ** Significantly different from Wt-tp on
HFC diet. *p<0.05, **p<0.01.
doi: 10.1371/journal.pone.0078792.g002
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Despite no difference in the foamy appearance of Kupffer
cells, caspase-1/11-/--tp mice have reduced lysosomal
dysfunction and less cholesterol crystallization than Wt-tp mice
on HFC.
To determine whether inflammasome activation affects the
foamy appearance of KCs, staining of liver sections against
CD68, a macrophage marker that stains KCs, was performed.
The comparison of CD68 positive cells revealed no difference
between Wt-tp and caspase-1/11-/--tp animals (Figure 3A+B).
These data were confirmed by gene expression analysis of
Cd68, which also showed an increase after 3 months of HFC
diet and no difference between both transplanted groups upon
HFC (Figure 3C). Additionally, no difference in steatosis was
observed (data not shown). These data suggest that
inflammasome activation has no effect on the foamy
appearance of KCs.
To assess lysosomal dysfunction, the hepatic activity of the
lysosomal enzyme cathepsin D was measured. In line with the
differences in hepatic inflammation, the livers of
caspase-1/11-/--tp mice had less cathepsin D activity than those
of Wt-tp mice on HFC diet (Figure 3D) (p=0.0042). Despite a
significant effect, the difference in cathepsin D activity is small
and it is not clear whether it is biological relevant. Since
lysosomal dysfunction and disturbed lysosomal enzyme activity
is associated with the presence of cholesterol crystals, electron
microscopy was performed to study any differences in KC
structure and cholesterol crystallization. As demonstrated in
Figure 3E+F, KCs of caspase-1/11-/--tp mice on HFC diet had
considerably fewer cholesterol crystals than KCs of Wt-tp mice.
Scoring electron microscopy pictures from 30 Kupffer cells from
each experimental group revealed that caspase-1/11-/--tp mice
had significantly less cholesterol crystals inside their Kupffer
cells than Wt-tp mice after 3 months of HFC (Figure 3E). These
data indicate that inflammasome activation stimulates
cholesterol crystallization and is associated with disturbed
lysosomal function.
Figure 3.  Foamy appearance of Kupffer cells, Cathepsin D activity and electron microscopy of KCs.  (A, B) Representative
pictures of CD68 staining (200x magnification) after 3 months of HFC feeding in Wt-tp and caspase-1/11-/--tp mice, respectively. (C)
Gene expression analysis of macrophage and Kupffer cell marker Cd68 in liver of Wt-tp and caspase-1/11-/--tp mice. (D) Activity of
the lysosomal enzyme cathepsin D in livers of Wt-tp and caspase-1/11-/--tp mice. (E) Scoring for the amount of cholesterol
crystallization inside Kupffer cells; 0 indicates that no cholesterol crystals were present while 5 indicates the highest amount of
cholesterol crystals present. (F) Representative electron microscopy pictures of KCs from Wt-tp and caspase-1/11-/--tp mice on HFC
diet. Lysosomes are indicated in black by acid phosphatase staining and cholesterol crystals are indicated by arrows. Data are
represented as mean +/- SEM and were set relative to the Wt-tp group on chow diet. *Significantly different from Wt-tp on HFC diet.
*p<0.05.
doi: 10.1371/journal.pone.0078792.g003
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Caspase-1/11-/--tp mice have increased cholesterol
efflux and restored autophagy compared to Wt-tp mice
on HFC
ATP binding cassette transporter a1 (Abca1) and ATP
binding cassette transporter g1 (Abcg1) are two well-known
cholesterol transporters responsible for cholesterol efflux. To
investigate whether the stimulation of cholesterol crystallization
by caspase-1 is related to cholesterol efflux, gene expression
analysis of Abca1 and Abcg1 in isolated KCs was performed.
On both chow and HFC diet, expression of Abca1 (p=0.0099;
p=0.0001) and Abcg1 (p=0.0025; p=0.0006) was increased in
KCs of caspase-1/11-/--tp mice compared to Wt-tp mice (Figure
4A). Interestingly, in KCs of caspase-1/11-/--tp mice on HFC
diet, increased expression of Abca1 (p=0.0005) and Abcg1
(p=0.0009) was found compared to mice on chow diet,
whereas HFC diet had no effect in KCs of Wt-tp mice (Figure
4A).
To investigate whether the decreased cholesterol efflux in
KCs of caspase-1/11-/- -tp mice is related to disturbed
autophagy, electron microscopy was used to quantify the
number of lipid-containing autophagosomes present inside KCs
(Figure 4B+C). We determined the average amount of
autophagosomes per KC from each transplanted group and
found that the higher degree of cholesterol crystallization
observed in Wt-tp mice on HFC diet is accompanied by a
higher average autophagosome number per KC relative to
caspase-1/11-/--tp mice on HFC diet (Figure 4D) (p<0.001),
indicative of abnormal autophagy. Furthermore, expression of
Lamp2 in isolated KCs from caspase-1/11-/--tp mice was
increased compared to Wt-tp mice, both on chow (p=0.0181)
and HFC diet (p=0.0094) (Figure 4E). Altogether, these data
indicate that increased hepatic inflammation and cholesterol
crystallization in caspase-1/11-/--tp mice is associated with
Figure 4.  Parameters for cholesterol efflux and autophagy.  (A) Gene expression analysis of ABC-transporter a1 (Abca1) and
ABC-transporter g1 (Abcg1) in isolated KCs. (B, C) Representative electron microscopy images of KCs from Wt-tp (B) and
caspase-1/11-/--tp (C) mice on HFC diet. Double membranes surrounding lipid droplets (autophagosomes) are indicated by arrows.
(D) Average autophagosome number per Kupffer cell. (E) Gene expression analysis of lysosomal-associated membrane protein 2
(Lamp2) in isolated KCs. Data are represented as mean +/- SEM and were set relative to the Wt-tp group on chow diet.
*Significantly different from Wt-tp on HFC diet. **p<0.01, ***p<0.001.
doi: 10.1371/journal.pone.0078792.g004
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disturbed cholesterol efflux and affected autophagic activity in
KCs.
To further examine the effect of inflammasome activation on
autophagy in macrophages, bone marrow derived
macrophages (BMDM) from Wt and caspase-1/11-/- mice were
incubated with oxLDL for 24h. Incubation with oxLDL increased
LC3-II levels in macrophages from Wt and caspase-1/11-/- mice
(Figure 5A). After 24h oxLDL incubation in Wt macrophages,
levels of LC3-II increased to a higher extent than in
caspase-1/11-/- macrophages (Figure 5B), while no difference
was observed in levels of p62 (Figure 5C), suggesting that
although some components of the autophagic process are not
affected, the final fusion/degradation step with the lysosome is
impaired. These data further strengthen our in vivo findings that
inflammasome activation in macrophages is associated with
affected autophagic activity.
Discussion
In the present study, we investigated whether inflammasome
activation in Kupffer cells stimulates the formation of
cholesterol crystals and thereby contributes to the inflammatory
response during NASH. Our results indeed indicate for the first
time an important role for inflammasome activation in Kupffer
cells in stimulating cholesterol crystallization, thereby triggering
hepatic inflammation. Our data suggest that insufficient
cholesterol efflux and disturbed autophagy are two important
mechanisms underlying the formation of inflammasome
mediated cholesterol crystals. Inflammasomes thus contribute
to a vicious cycle whereby, upon activation, new crystals are
formed which then further enhance inflammasome activation.
Inflammasome activation in KCs plays a major role in
hepatic inflammation
Despite much effort, the exact role of inflammasome
activation during the development of NASH remains poorly
understood. Recent studies describing the role of caspase-1
and caspase 11 during NASH produced conflicting results. On
the one hand, when compared with control mice,
caspase-1/11-/- mice receiving a methionine and choline-
deficient (MCD) diet for 6 weeks were observed to have lower
expression levels of genes involved in inflammation and
fibrosis [14]. In line with our findings, Dixon et al. also showed
that KC depletion by clodronate injection suppressed
caspase-1 activation and reduced fibrogenesis, suggesting that
KCs are the most important cellular source of active caspase-1
during MCD-induced NASH [14]. In another recent study from
the same group, it was shown that mice deficient for caspase-1
and caspase-11 were protected from high fat-induced
steatosis, inflammation and early fibrogenesis [15]. Conversely,
another study showed that the inflammasome negatively
regulates NASH progression. Here, caspase-1/11-/- mice fed an
MCD diet for 4 weeks had higher levels of ALT and AST, as
well as more microvesicular and macrovesicular hepatic
steatosis, and more hepatic inflammation than their C57Bl6
wild-type controls fed the same diet [16]. Additional evidence
came from an experiment in the same study in which bone
marrow from Nlrp3-/- or Asc-/- mice was transplanted into wild-
Figure 5.  Autophagy in Wt and caspase-1/11-/- bone marrow derived macrophages.  (A) Western blots of LC3-II in Wt and
caspase-1/11-/- bone marrow derived macrophages (BMDM) with and without oxLDL incubation for 24h. (B, C) Quantification of
western blot for LC3-II and p62 levels in BMDM from Wt and caspase-1/11-/- mice after oxLDL incubation (24h), corrected for actine
levels. Data from three separate experiments are represented as mean +/- SEM and were set relative to Wt BMDM. *Significantly
different from Wt BMDM. *p<0.05.
doi: 10.1371/journal.pone.0078792.g005
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type mice, from which the authors concluded that ablation of
these genes in hematopoietic cells has no effect on hepatic
inflammation after MCD feeding [16].
Although the reason for these contradictive findings is not
clear, a difference in gut microbiota or in housing conditions are
fitting explanations. For example, gut microbiota are known to
undergo changes in obese individuals, as well as in obese
mouse models [17], and diet is known to influence gut
microbiota composition in both animal models and humans
[18,19]. It is therefore reasonable to hypothesize that the
contradiction regarding the role of inflammasome activation in
hematopoietic cells may be related to the fact that we used an
HFC diet while Henao-Mejia et al. used an MCD diet. After all,
different dietary regimes can lead to diverse inflammatory
effects: MCD feeding results in more acute inflammation and
severe liver damage, whereas mice fed an HFC diet have more
chronic low-grade hepatic inflammation. It is therefore possible
that the causes of inflammasome activation depend on the
specific type and trigger of inflammation.
Another explanation for the observed differences could be
related to the fact that the present study used hyperlipidemic
Ldlr-/- mice with a human-like lipid profile while the other study
used normolipidemic wild-type (C57Bl6) mice. The drastic
differences between these mice with regard to plasma lipid
levels may also affect activation of the inflammasome via the
effect on autophagy for example. Increased lipid levels have
been shown to repress autophagic function [20], thereby
possibly enhancing IL-1b secretion as autophagy is able to
control IL-1b production [21–23].
While we have investigated the inflammasome in relation to
NASH, others have studied its relation to atherosclerosis. Our
current data are in line with most findings regarding the role of
inflammasomes in atherosclerosis [24,25]. Studies have shown
that ApoE-/-Caspase-1/11-/- double deficient mice have fewer
signs of atherosclerosis than ApoE-/- mice, meaning that
inflammasome activation is also a key factor in the
inflammatory response during atherosclerosis [24,25]. It is also
important to note that, in the same model as used here, Ldlr-/-
mice reconstituted with bone marrow from Nlrp3-/- or Asc-/- mice
had less atherosclerosis after an HFC diet, indicating a
reduced inflammatory response during disturbed
inflammasome activation and thereby confirming our results [5].
We suggest that the involvement of inflammasomes in
inflammation is influenced by the status of immune responses,
as well as by the specific disease models investigated. Our
data support the strong involvement of inflammasome
activation in hematopoietic cells, especially KCs, in the context
of hepatic inflammation. Of note, it is important to keep in mind
that in addition to Kupffer cells, other hematopoietic cells are
also lacking caspase-1 and caspase-11 in the caspase-1/11-/--
tp mice. These cells secrete myeloid precursors and as such
can directly contribute to the reduction in the inflammatory
response [26]. Moreover, KCs can also indirectly influence the
phenotype of neighboring hepatocytes and other immune cells
via the production of inflammatory cytokines such as TNF and
interleukins, and cross-talking with other liver cell types [27].
Therefore, it is very likely that in addition to Kupffer cells, other
liver cells modulate directly and indirectly the hepatic
intracellular inflammatory signaling pathway.
Inflammasome activation promotes cholesterol
crystallization via reduced cholesterol efflux
During atherosclerosis, intracellular lipid accumulation in
foam cells can result in the formation of cholesterol crystals
[28]. Since atherosclerosis and NASH share similar hallmarks
[29], it is likely that cholesterol is also crystallized inside KCs
during NASH development. Indeed, previously we confirmed
that cholesterol crystallization in KCs is associated with hepatic
inflammation in hyperlipidemic Ldlr-/- mice fed an HFC diet [30].
Additionally, it was recently shown that also human NASH
patients have cholesterol crystallization and the formation of
“crown-like” structures in activated KCs. In this way they were
able to distinguish NASH from simple steatosis, as in these
patients cholesterol crystals were not formed [31]. Others have
shown that crystalline structures activate the inflammasome by
causing lysosomal damage [32,33] and that cholesterol crystals
can lead to lysosomal rupture and subsequently the release of
cathepsin B and the generation of ROS, both described as
activators of the inflammasome [34]. In the current study, we
have demonstrated for the first time that inflammasome
activation contributes to the promotion of cholesterol
crystallization in the liver.
Although the exact mechanisms behind this are not yet clear,
we propose that reduced cholesterol efflux and disturbed
autophagy, the process by which cytoplasmic components are
broken down and recycled, represent an important link
between lysosomal cholesterol accumulation, inflammasome
activation and cholesterol crystal formation. From literature it is
known that reduced cholesterol efflux is associated with foam
cell formation, whereas increased cholesterol crystals are
found in foamy macrophages. In macrophages, cholesterol
efflux via ABCA1 and ABCG1 prevent the excessive
accumulation of lipids, thereby protecting against the formation
of atherosclerotic lesions [35]. Moreover, animal studies show
that in transgenic mice disruption of ABCA1 gene induces
atherosclerosis [36], in which it was shown that cholesterol
crystals activate the inflammasome [5].
Disturbed autophagy as driver for hepatic inflammation
We propose that autophagy is dysfunctional as indicated by
increased levels of both LC3-II and p62 in our Wt macrophages
in our in vitro set-up. Due to the fact that LC3-II and p62 are
both degraded in the autolysosome, the lysosomal-dependent
turnover of these proteins has emerged as a measure of
autophagic flux [37]. Thus, accumulation of LC3-II and p62
indicates autophagic flux inhibition at any point beyond
autophagosome formation, while increased p62 alone indicates
reduced autophagy [37]. Therefore, our novel findings indicate
that autophagy activity in KCs is affected upon HFC and may
therefore lead to hepatic inflammation in this way. Additionally,
it was recently highlighted that cholesterol efflux by lipid-loaden
macrophages is dependent on autophagy, as macrophages
with impaired autophagy were not able to clear accumulated
cholesterol in vivo. Furthermore, autophagy-mediated
cholesterol efflux was shown to be primarily Abca1 dependent
Inflammasome Activation in Macrophages during NASH
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[38]. These data can explain our observations regarding
reduced cholesterol efflux and abnormal autophagy, as shown
by the accumulation of autophagosomes and reduced Lamp2
expression in KCs. Lamp2 deficiency was previously shown to
be associated with accumulation of autophagic vacuoles in
different tissues such as muscle, heart and liver [39]. In
humans, a mutated Lamp2 gene results in Danon disease,
characterized by intracytoplasmic vacuoles containing
autophagic material and glycogen in skeletal and cardiac
muscle cells [40]. Since autophagy is disturbed in lysosomal
storage disorders [41] and dysfunctional autophagy results in
inflammasome activation and increased accumulation of
cholesterol crystals [42], further increases in cholesterol
crystallization may result in a vicious cycle of inflammation
through further activation of the inflammasome. Such a
mechanism might explain the sustained inflammatory response
seen in the liver.
A number of other studies provide further evidence that
disturbed autophagy may also contribute to hepatic
inflammation. Firstly, autophagy has been shown to control
IL-1b production by targeting pro-IL-1b for lysosomal
degradation and by regulating NLRP3 inflammasome activation
[23]. Secondly, it has been shown to regulate hepatocyte lipid
metabolism, a process called lipophagy [20,43]. Taken together
with our current findings this suggests a link between abnormal
autophagy, inflammasome activation and cholesterol
crystallization during the development of NASH.
In summary, our data demonstrate that inflammasome
mediated cholesterol crystallization in KCs is an important
factor during the progression of hepatic inflammation in NASH.
Of note, in addition to caspase-1, the mice that we have used
are also lacking caspase-11. Caspase-11 was found to be
important in non-canonical inflammasome activation, which is
mainly involved in inflammation driven by gram-negative
bacteria [44]. As inflammasome activation by cholesterol
crystals is known to be caspase-1 dependent [45], it is most
likely that caspase-11 plays a minor role in this process.
Nevertheless, as it was shown that caspase-11 is involved in
inflammation and autophagosome autophagosome fusion
[44,46], we cannot exclude the possibility that caspase-11 is
also playing a role in cholesterol crystallization and triggering
hepatic inflammation during NASH. More in general, blocking
inflammasome activation in KCs can be seen as a potential
target for therapy options in obesity related diseases. Future
studies should focus on the mechanisms that link autophagy,
inflammasomes and cholesterol crystals in relation to the
development of hepatic inflammation.
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Gene expression analysis of transforming growth factor beta
(Tgf-β) and collagen 1A1 (Col1a1) in whole liver. (E) ALT
measurements in plasma from Wt-tp and caspase-1/11-/--tp
mice. Data were set relative to the Wt-tp group on chow diet.
*Significantly different from Wt-tp on HFC diet. *p<0.05.
(TIF)
Author Contributions
Conceived and designed the experiments: TH VB SMAW PJvG
FV MLJJ MMFS NV CJB GHK RS MGN MHH RSS. Analyzed
the data: TH VB SMAW PJvG FV MLJJ MMFS NV CJB GHK
RS MGN MHH RSS GHK. Wrote the manuscript: TH VB
SMAW PJvG FV MLJJ MMFS NV CJB GHK RS MGN MHH
RSS. Acquisition of data, critical revision of the manuscript,
technical and material support and study supervision: TH VB
SMAW PJvG FV MLJJ MMFS NV CJB GHK RS MGN MHH
RSS.
References
1. Farrell GC, van Rooyen D, Gan L, Chitturi S (2012) NASH is an
Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic
Implications. Gut Liver 6: 149-171. doi:10.5009/gnl.2012.6.2.149.
PubMed: 22570745.
2. Bieghs V, Wouters K, van Gorp PJ, Gijbels MJ, de Winther MP, et al.
(2010) Role of scavenger receptor A and CD36 in diet-induced
nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology
138: 2477-2486, e2471-2473
3. Bieghs V, Verheyen F, van Gorp PJ, Hendrikx T, Wouters K et al.
(2012) Internalization of modified lipids by CD36 and SR-A leads to
hepatic inflammation and lysosomal cholesterol storage in Kupffer cells.
PLOS ONE 7: e34378. doi:10.1371/journal.pone.0034378. PubMed:
22470565.
4. Bieghs V, Hendrikx T, van Gorp PJ, Verheyen F, Guichot YD et al.
(2013) The Cholesterol Derivative 27-Hydroxycholesterol Reduces
Steatohepatitis in Mice. Gastroenterology, 144: 167–178.e1 PubMed:
23041327.
5. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G et al. (2010)
NLRP3 inflammasomes are required for atherogenesis and activated
by cholesterol crystals. Nature 464: 1357-1361. doi:10.1038/
nature08938. PubMed: 20428172.
6. Lukens JR, Dixit VD, Kanneganti TD (2011) Inflammasome activation in
obesity-related inflammatory diseases and autoimmunity. Discov Med
12: 65-74. PubMed: 21794210.
7. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a
molecular platform triggering activation of inflammatory caspases and
processing of proIL-beta. Mol Cell 10: 417-426. doi:10.1016/
S1097-2765(02)00599-3. PubMed: 12191486.
8. Stutz A, Golenbock DT, Latz E (2009) Inflammasomes: too big to miss.
J Clin Invest 119: 3502-3511. doi:10.1172/JCI40599. PubMed:
19955661.
9. Wang S, Miura M, Jung YK, Zhu H, Li E et al. (1998) Murine
caspase-11, an ICE-interacting protease, is essential for the activation
of ICE. Cell 92: 501-509. doi:10.1016/S0092-8674(00)80943-5.
PubMed: 9491891.
10. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S et al.
(2011) Non-canonical inflammasome activation targets caspase-11.
Nature 479: 117-121. doi:10.1038/nature10558. PubMed: 22002608.
11. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H et al. (2008)
Dietary cholesterol, rather than liver steatosis, leads to hepatic
inflammation in hyperlipidemic mouse models of nonalcoholic
steatohepatitis. Hepatology 48: 474-486. doi:10.1002/hep.22363.
PubMed: 18666236.
12. Wisse E, Braet F, Duimel H, Vreuls C, Koek G et al. (2010) Fixation
methods for electron microscopy of human and other liver. World J
Gastroenterol 16: 2851-2866. doi:10.3748/wjg.v16.i23.2851. PubMed:
20556830.
13. Jansen HJ, van Essen P, Koenen T, Joosten LA, Netea MG et al.
(2012) Autophagy activity is up-regulated in adipose tissue of obese
Inflammasome Activation in Macrophages during NASH
PLOS ONE | www.plosone.org 9 December 2013 | Volume 8 | Issue 12 | e78792
individuals and modulates proinflammatory cytokine expression.
Endocrinology 153: 5866-5874. doi:10.1210/en.2012-1625. PubMed:
23117929.
14. Dixon LJ, Berk M, Thapaliya S, Papouchado BG, Feldstein AE (2012)
Caspase-1-mediated regulation of fibrogenesis in diet-induced
steatohepatitis. Lab Invest 92: 713-723. doi:10.1038/labinvest.2012.45.
PubMed: 22411067.
15. Dixon LJ, Flask CA, Papouchado BG, Feldstein AE, Nagy LE (2013)
Caspase-1 as a central regulator of high fat diet-induced non-alcoholic
steatohepatitis. PLOS ONE 8: e56100. doi:10.1371/journal.pone.
0056100. PubMed: 23409132.
16. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ et al. (2012)
Inflammasome-mediated dysbiosis regulates progression of NAFLD
and obesity. Nature 482: 179-185. PubMed: 22297845.
17. Musso G, Gambino R, Cassader M (2010) Obesity, diabetes, and gut
microbiota: the hygiene hypothesis expanded? Diabetes Care 33:
2277-2284. doi:10.2337/dc10-0556. PubMed: 20876708.
18. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM et al.
(2012) Gut microbiota composition correlates with diet and health in the
elderly. Nature 488: 178-184. doi:10.1038/nature11319. PubMed:
22797518.
19. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady
M, et al. (2009) High-fat diet determines the composition of the murine
gut microbiome independently of obesity. Gastroenterology 137:
1716-1724 e1711-1712
20. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I et al. (2009) Autophagy
regulates lipid metabolism. Nature 458: 1131-1135. doi:10.1038/
nature07976. PubMed: 19339967.
21. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG et al. (2008) Loss of
the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta
production. Nature 456: 264-268. doi:10.1038/nature07383. PubMed:
18849965.
22. Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M et al. (2012)
Activation of autophagy by inflammatory signals limits IL-1beta
production by targeting ubiquitinated inflammasomes for destruction.
Nat Immunol 13: 255-263. doi:10.1038/ni.2215. PubMed: 22286270.
23. Harris J, Hartman M, Roche C, Zeng SG, O'Shea A et al. (2011)
Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for
degradation. J Biol Chem 286: 9587-9597. doi:10.1074/
jbc.M110.202911. PubMed: 21228274.
24. Gage J, Hasu M, Thabet M, Whitman SC (2012) Caspase-1 deficiency
decreases atherosclerosis in apolipoprotein E-null mice. Can J Cardiol
28: 222-229. doi:10.1016/j.cjca.2012.07.331. PubMed: 22265992.
25. Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A et al. (2012)
Critical role of caspase-1 in vascular inflammation and development of
atherosclerosis in Western diet-fed apolipoprotein E-deficient mice.
Biochem Biophys Res Commun, 425: 162–8. PubMed: 22819845.
26. Aparicio-Vergara M, Shiri-Sverdlov R, de Haan G, Hofker MH (2010)
Bone marrow transplantation in mice as a tool for studying the role of
hematopoietic cells in metabolic and cardiovascular diseases.
Atherosclerosis 213: 335-344. doi:10.1016/j.atherosclerosis.
2010.05.030. PubMed: 20576267.
27. Racanelli V, Rehermann B (2006) The liver as an immunological organ.
Hepatology 43: S54-S62. doi:10.1002/hep.21060. PubMed: 16447271.
28. De Nardo D, Latz E (2011) NLRP3 inflammasomes link inflammation
and metabolic disease. Trends Immunol 32: 373-379. doi:10.1016/j.it.
2011.05.004. PubMed: 21733753.
29. Bieghs V, Rensen PC, Hofker MH, Shiri-Sverdlov R (2012) NASH and
atherosclerosis are two aspects of a shared disease: central role for
macrophages. Atherosclerosis 220: 287-293. doi:10.1016/
j.atherosclerosis.2011.08.041. PubMed: 21930273.
30. Bieghs V, van Gorp PJ, Walenbergh SM, Gijbels MJ, Verheyen F et al.
(2012) Specific immunization strategies against oxidized low-density
lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice.
Hepatology, 56: 894–903. PubMed: 22334337.
31. Ioannou GN, Haigh WG, Thorning D, Savard C (2013) Hepatic
Cholesterol Crystals and Crown-Like Structures Distinguish NASH from
Simple Steatosis. J Lipid Res, 54: 1326–34. PubMed: 23417738.
32. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG et al. (2008)
The NALP3 inflammasome is involved in the innate immune response
to amyloid-beta. Nat Immunol 9: 857-865. doi:10.1038/ni.1636.
PubMed: 18604209.
33. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H et al. (2008)
Silica crystals and aluminum salts activate the NALP3 inflammasome
through phagosomal destabilization. Nat Immunol 9: 847-856. doi:
10.1038/ni.1631. PubMed: 18604214.
34. Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: The
convergence of multiple signalling pathways on ROS production? Nat
Rev Immunol 10: 210-215. doi:10.1038/nri2725. PubMed: 20168318.
35. Cavelier C, Lorenzi I, Rohrer L, von Eckardstein A (2006) Lipid efflux by
the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim
Biophys Acta 1761: 655-666. doi:10.1016/j.bbalip.2006.04.012.
PubMed: 16798073.
36. Aiello RJ, Brees D, Bourassa PA, Royer L, Lindsey S et al. (2002)
Increased atherosclerosis in hyperlipidemic mice with inactivation of
ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 22: 630-637.
doi:10.1161/01.ATV.0000014804.35824.DA. PubMed: 11950702.
37. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G et al.
(2008) Guidelines for the use and interpretation of assays for
monitoring autophagy in higher eukaryotes. Autophagy 4: 151-175.
PubMed: 18188003.
38. Ouimet M, Franklin V, Mak E, Liao X, Tabas I et al. (2011) Autophagy
regulates cholesterol efflux from macrophage foam cells via lysosomal
acid lipase. Cell Metab 13: 655-667. doi:10.1016/j.cmet.2011.03.023.
PubMed: 21641547.
39. Eskelinen EL, Illert AL, Tanaka Y, Schwarzmann G, Blanz J et al.
(2002) Role of LAMP-2 in lysosome biogenesis and autophagy. Mol
Biol Cell 13: 3355-3368. doi:10.1091/mbc.E02-02-0114. PubMed:
12221139.
40. Nishino I, Fu J, Tanji K, Yamada T, Shimojo S et al. (2000) Primary
LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and
myopathy (Danon disease). Nature 406: 906-910. doi:
10.1038/35022604. PubMed: 10972294.
41. Settembre C, Fraldi A, Jahreiss L, Spampanato C, Venturi C et al.
(2008) A block of autophagy in lysosomal storage disorders. Hum Mol
Genet 17: 119-129. PubMed: 17913701. Available online at: PubMed:
17913701
42. Razani B, Feng C, Coleman T, Emanuel R, Wen H et al. (2012)
Autophagy links inflammasomes to atherosclerotic progression. Cell
Metab 15: 534-544. doi:10.1016/j.cmet.2012.02.011. PubMed:
22440612.
43. Singh R, Cuervo AM (2012) Lipophagy: connecting autophagy and lipid
metabolism. Int J Cell Biol 2012: 282041
44. Broz P, Monack DM (2013) Noncanonical inflammasomes: caspase-11
activation and effector mechanisms. PLoS Pathog 9: e1003144.
PubMed: 23468620.
45. Rajamäki K, Lappalainen J, Oörni K, Välimäki E, Matikainen S et al.
(2010) Cholesterol crystals activate the NLRP3 inflammasome in
human macrophages: a novel link between cholesterol metabolism and
inflammation. PLOS ONE 5: e11765. doi:10.1371/journal.pone.
0011765. PubMed: 20668705.
46. Akhter A, Caution K, Abu Khweek A, Tazi M, Abdulrahman BA et al.
(2012) Caspase-11 promotes the fusion of phagosomes harboring
pathogenic bacteria with lysosomes by modulating actin polymerization.
Immunity 37: 35-47. doi:10.1016/j.immuni.2012.05.001. PubMed:
22658523.
Inflammasome Activation in Macrophages during NASH
PLOS ONE | www.plosone.org 10 December 2013 | Volume 8 | Issue 12 | e78792
